Chengdu Kanghua Biological Products (300841) Income Statement & Earnings

75.66
+0.16+0.21%

Market Closed Jan 16 15:00 CST

9.83BMarket Cap54.04P/E (TTM)

Chengdu Kanghua Biological Products (300841) Income Statement

All

YOY

Hide blank lines

(Q9)Sep 30, 2025

(Q6)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

Total operating revenue

-20.78%840.06M

-34.70%483.92M

-55.70%137.94M

-9.23%1.43B

7.10%1.06B

16.81%741.08M

11.96%311.37M

9.03%1.58B

-6.12%990.06M

-3.84%634.44M

Operating revenue

-20.78%840.06M

-34.70%483.92M

-55.70%137.94M

-9.23%1.43B

7.10%1.06B

16.81%741.08M

11.96%311.37M

9.03%1.58B

-6.12%990.06M

-3.84%634.44M

Other operating revenue

----

-99.97%27.04K

----

3,747,681.67%106.25M

----

3,747,465.37%106.24M

----

-99.11%2.84K

----

--2.84K

Total operating cost

6.22%613.12M

-4.70%348.22M

-16.78%112.23M

-8.77%875.18M

-1.54%577.2M

0.60%365.39M

-19.05%134.86M

22.80%959.26M

15.87%586.25M

22.16%363.21M

Operating cost

8.32%64.78M

-10.25%34.93M

-36.97%7.69M

-19.62%83.01M

-6.21%59.8M

-5.37%38.91M

-32.10%12.2M

10.88%103.27M

-4.57%63.76M

2.43%41.12M

Operating tax surcharges

-7.80%6.1M

-11.52%4.65M

-62.75%533.95K

5.27%10.28M

12.12%6.62M

17.39%5.26M

26.47%1.43M

18.61%9.76M

2.94%5.9M

9.20%4.48M

Operating expense

10.46%379.85M

-2.03%204.35M

-22.92%55.98M

10.68%547.12M

27.24%343.88M

19.12%208.59M

-7.34%72.63M

15.46%494.32M

4.95%270.26M

14.18%175.11M

Administration expense

1.83%82.61M

-3.60%52.16M

-6.15%23.44M

4.16%111.27M

22.44%81.13M

33.72%54.11M

12.59%24.97M

29.22%106.82M

14.31%66.26M

2.19%40.46M

Financial expense

51.36%-3.23M

54.20%-2.75M

79.16%-459.54K

-7.64%-8.55M

-13.14%-6.63M

-59.14%-6M

-28.00%-2.2M

27.55%-7.95M

40.27%-5.86M

53.37%-3.77M

-Interest expense (Financial expense)

-27.94%2.86M

-23.44%2.04M

-20.83%1.12M

11.86%5.38M

12.04%3.97M

13.30%2.67M

37.51%1.41M

50.71%4.81M

76.90%3.54M

184.89%2.36M

-Interest Income (Financial expense)

33.49%-6.04M

31.78%-4.74M

56.12%-1.52M

2.46%-12.28M

1.76%-9.08M

-17.00%-6.94M

-24.89%-3.46M

11.68%-12.59M

22.04%-9.24M

34.03%-5.93M

Research and development

-10.18%83M

-14.95%54.88M

-2.99%25.05M

-47.81%132.05M

-50.30%92.41M

-39.02%64.53M

-46.92%25.83M

40.62%253.03M

45.56%185.93M

55.17%105.81M

Credit Impairment Loss

63.03%-4.32M

37.96%-13.69M

-14.55%-6.36M

-206.40%-30.14M

-60.63%-11.69M

-117.30%-22.07M

26.98%-5.56M

72.19%-9.84M

63.68%-7.28M

44.77%-10.16M

Asset Impairment Loss

-438.17%-7.69M

-152.24%-72.71K

-185.67%-80.89K

0.03%-1.63M

-210.47%-1.43M

129.91%139.17K

151.32%94.42K

81.27%-1.63M

236.90%1.29M

46.41%-465.23K

Other net revenue

74.44%-5.25M

58.13%-10.16M

-29.59%-5.65M

-115.33%-89.41M

-535.12%-20.53M

-452.04%-24.28M

-178.90%-4.36M

-308.64%-41.52M

102.28%4.72M

948.03%6.9M

Fair value change income

123.70%1.9M

141.46%1.9M

-79.68%106.03K

-89.02%-59.73M

-173.17%-8.01M

-129.64%-4.58M

-96.00%521.7K

-160.89%-31.6M

-6.44%10.94M

62.00%15.44M

Invest income

214.41%3.01M

-86.28%109.78K

19.78%109.78K

155.55%891.25K

--957.51K

--800.42K

--91.66K

-93.04%348.75K

----

-Including: Investment income associates

----

---146.67K

----

Asset deal income

99.50%-8.91K

---8.91K

----

-860.53%-1.79M

---1.79M

----

---186.83K

----

Other revenue

29.99%1.86M

12.01%1.6M

18.76%583.73K

116.58%2.99M

687.23%1.43M

-31.00%1.43M

88.31%491.51K

-80.51%1.38M

-103.70%-244.09K

-46.85%2.08M

Operating profit

-52.08%221.7M

-64.28%125.54M

-88.35%20.06M

-18.96%467.28M

13.25%462.65M

26.35%351.41M

47.09%172.15M

-15.88%576.61M

-25.85%408.53M

-23.09%278.12M

Add:Non operating Income

----

-59.54%6.27K

-99.96%15.85

----

-87.34%15.5K

-63.85%44.07K

208.45%15.43K

Less:Non operating expense

-78.29%46.49K

-63.90%40.24K

-38.05%6.61K

-89.88%266.64K

-60.27%214.17K

-53.95%111.46K

-93.32%10.68K

43.83%2.63M

-54.49%539.07K

-78.56%242.03K

Total profit

-52.07%221.65M

-64.28%125.5M

-88.35%20.06M

-18.64%467.02M

13.33%462.44M

26.42%351.3M

47.27%172.14M

-16.06%573.99M

-25.80%408.03M

-22.92%277.9M

Less:Income tax cost

-42.44%32.54M

-75.47%10.98M

-102.87%-650.8K

5.55%68.37M

44.62%56.53M

50.71%44.75M

93.85%22.68M

-24.44%64.78M

-41.27%39.09M

-33.79%29.69M

Net profit

-53.41%189.11M

-62.64%114.52M

-86.15%20.71M

-21.71%398.65M

10.02%405.9M

23.51%306.55M

42.09%149.47M

-14.86%509.22M

-23.66%368.94M

-21.37%248.2M

Net profit from continuing operation

-53.41%189.11M

----

-86.15%20.71M

-21.71%398.65M

10.02%405.9M

----

42.09%149.47M

-14.86%509.22M

-23.66%368.94M

----

Net profit of parent company owners

-53.41%189.11M

-62.64%114.52M

-86.15%20.71M

-21.71%398.65M

10.02%405.9M

23.51%306.55M

42.09%149.47M

-14.86%509.22M

-23.66%368.94M

-21.37%248.2M

Earning per share

Basic earning per share

-52.59%1.4553

-61.76%0.8813

-85.77%0.1594

-20.47%3.0279

11.29%3.0697

24.20%2.3049

42.45%1.1204

-14.73%3.8073

-23.52%2.7584

-21.17%1.8558

Diluted earning per share

-52.59%1.4553

-61.76%0.8813

-85.77%0.1594

-20.47%3.0279

11.30%3.0697

24.23%2.3049

42.49%1.1204

-14.71%3.8073

-23.53%2.758

-21.19%1.8554

Other composite income

Total composite income

-53.41%189.11M

-62.64%114.52M

-86.15%20.71M

-21.71%398.65M

10.02%405.9M

23.51%306.55M

42.09%149.47M

-14.86%509.22M

-23.66%368.94M

-21.37%248.2M

Total composite income of parent company owners

-53.41%189.11M

-62.64%114.52M

-86.15%20.71M

-21.71%398.65M

10.02%405.9M

23.51%306.55M

42.09%149.47M

-14.86%509.22M

-23.66%368.94M

-21.37%248.2M

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion

Auditor

Lixin Certified Public Accountants (Special General Partnership)

	(Q9)Sep 30, 2025	(Q6)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023
Total operating revenue	-20.78%840.06M	-34.70%483.92M	-55.70%137.94M	-9.23%1.43B	7.10%1.06B	16.81%741.08M	11.96%311.37M	9.03%1.58B	-6.12%990.06M	-3.84%634.44M
Operating revenue	-20.78%840.06M	-34.70%483.92M	-55.70%137.94M	-9.23%1.43B	7.10%1.06B	16.81%741.08M	11.96%311.37M	9.03%1.58B	-6.12%990.06M	-3.84%634.44M
Other operating revenue	----	-99.97%27.04K	----	3,747,681.67%106.25M	----	3,747,465.37%106.24M	----	-99.11%2.84K	----	--2.84K
Total operating cost	6.22%613.12M	-4.70%348.22M	-16.78%112.23M	-8.77%875.18M	-1.54%577.2M	0.60%365.39M	-19.05%134.86M	22.80%959.26M	15.87%586.25M	22.16%363.21M
Operating cost	8.32%64.78M	-10.25%34.93M	-36.97%7.69M	-19.62%83.01M	-6.21%59.8M	-5.37%38.91M	-32.10%12.2M	10.88%103.27M	-4.57%63.76M	2.43%41.12M
Operating tax surcharges	-7.80%6.1M	-11.52%4.65M	-62.75%533.95K	5.27%10.28M	12.12%6.62M	17.39%5.26M	26.47%1.43M	18.61%9.76M	2.94%5.9M	9.20%4.48M
Operating expense	10.46%379.85M	-2.03%204.35M	-22.92%55.98M	10.68%547.12M	27.24%343.88M	19.12%208.59M	-7.34%72.63M	15.46%494.32M	4.95%270.26M	14.18%175.11M
Administration expense	1.83%82.61M	-3.60%52.16M	-6.15%23.44M	4.16%111.27M	22.44%81.13M	33.72%54.11M	12.59%24.97M	29.22%106.82M	14.31%66.26M	2.19%40.46M
Financial expense	51.36%-3.23M	54.20%-2.75M	79.16%-459.54K	-7.64%-8.55M	-13.14%-6.63M	-59.14%-6M	-28.00%-2.2M	27.55%-7.95M	40.27%-5.86M	53.37%-3.77M
-Interest expense (Financial expense)	-27.94%2.86M	-23.44%2.04M	-20.83%1.12M	11.86%5.38M	12.04%3.97M	13.30%2.67M	37.51%1.41M	50.71%4.81M	76.90%3.54M	184.89%2.36M
-Interest Income (Financial expense)	33.49%-6.04M	31.78%-4.74M	56.12%-1.52M	2.46%-12.28M	1.76%-9.08M	-17.00%-6.94M	-24.89%-3.46M	11.68%-12.59M	22.04%-9.24M	34.03%-5.93M
Research and development	-10.18%83M	-14.95%54.88M	-2.99%25.05M	-47.81%132.05M	-50.30%92.41M	-39.02%64.53M	-46.92%25.83M	40.62%253.03M	45.56%185.93M	55.17%105.81M
Credit Impairment Loss	63.03%-4.32M	37.96%-13.69M	-14.55%-6.36M	-206.40%-30.14M	-60.63%-11.69M	-117.30%-22.07M	26.98%-5.56M	72.19%-9.84M	63.68%-7.28M	44.77%-10.16M
Asset Impairment Loss	-438.17%-7.69M	-152.24%-72.71K	-185.67%-80.89K	0.03%-1.63M	-210.47%-1.43M	129.91%139.17K	151.32%94.42K	81.27%-1.63M	236.90%1.29M	46.41%-465.23K
Other net revenue	74.44%-5.25M	58.13%-10.16M	-29.59%-5.65M	-115.33%-89.41M	-535.12%-20.53M	-452.04%-24.28M	-178.90%-4.36M	-308.64%-41.52M	102.28%4.72M	948.03%6.9M
Fair value change income	123.70%1.9M	141.46%1.9M	-79.68%106.03K	-89.02%-59.73M	-173.17%-8.01M	-129.64%-4.58M	-96.00%521.7K	-160.89%-31.6M	-6.44%10.94M	62.00%15.44M
Invest income	214.41%3.01M	-86.28%109.78K	19.78%109.78K	155.55%891.25K	--957.51K	--800.42K	--91.66K	-93.04%348.75K	----	----
-Including: Investment income associates	----	----	----	---146.67K	----	----	----	----	----	----
Asset deal income	99.50%-8.91K	---8.91K	----	-860.53%-1.79M	---1.79M	----	----	---186.83K	----	----
Other revenue	29.99%1.86M	12.01%1.6M	18.76%583.73K	116.58%2.99M	687.23%1.43M	-31.00%1.43M	88.31%491.51K	-80.51%1.38M	-103.70%-244.09K	-46.85%2.08M
Operating profit	-52.08%221.7M	-64.28%125.54M	-88.35%20.06M	-18.96%467.28M	13.25%462.65M	26.35%351.41M	47.09%172.15M	-15.88%576.61M	-25.85%408.53M	-23.09%278.12M
Add:Non operating Income	----	----	----	-59.54%6.27K	-99.96%15.85	----	----	-87.34%15.5K	-63.85%44.07K	208.45%15.43K
Less:Non operating expense	-78.29%46.49K	-63.90%40.24K	-38.05%6.61K	-89.88%266.64K	-60.27%214.17K	-53.95%111.46K	-93.32%10.68K	43.83%2.63M	-54.49%539.07K	-78.56%242.03K
Total profit	-52.07%221.65M	-64.28%125.5M	-88.35%20.06M	-18.64%467.02M	13.33%462.44M	26.42%351.3M	47.27%172.14M	-16.06%573.99M	-25.80%408.03M	-22.92%277.9M
Less:Income tax cost	-42.44%32.54M	-75.47%10.98M	-102.87%-650.8K	5.55%68.37M	44.62%56.53M	50.71%44.75M	93.85%22.68M	-24.44%64.78M	-41.27%39.09M	-33.79%29.69M
Net profit	-53.41%189.11M	-62.64%114.52M	-86.15%20.71M	-21.71%398.65M	10.02%405.9M	23.51%306.55M	42.09%149.47M	-14.86%509.22M	-23.66%368.94M	-21.37%248.2M
Net profit from continuing operation	-53.41%189.11M	----	-86.15%20.71M	-21.71%398.65M	10.02%405.9M	----	42.09%149.47M	-14.86%509.22M	-23.66%368.94M	----
Net profit of parent company owners	-53.41%189.11M	-62.64%114.52M	-86.15%20.71M	-21.71%398.65M	10.02%405.9M	23.51%306.55M	42.09%149.47M	-14.86%509.22M	-23.66%368.94M	-21.37%248.2M
Earning per share
Basic earning per share	-52.59%1.4553	-61.76%0.8813	-85.77%0.1594	-20.47%3.0279	11.29%3.0697	24.20%2.3049	42.45%1.1204	-14.73%3.8073	-23.52%2.7584	-21.17%1.8558
Diluted earning per share	-52.59%1.4553	-61.76%0.8813	-85.77%0.1594	-20.47%3.0279	11.30%3.0697	24.23%2.3049	42.49%1.1204	-14.71%3.8073	-23.53%2.758	-21.19%1.8554
Other composite income
Total composite income	-53.41%189.11M	-62.64%114.52M	-86.15%20.71M	-21.71%398.65M	10.02%405.9M	23.51%306.55M	42.09%149.47M	-14.86%509.22M	-23.66%368.94M	-21.37%248.2M
Total composite income of parent company owners	-53.41%189.11M	-62.64%114.52M	-86.15%20.71M	-21.71%398.65M	10.02%405.9M	23.51%306.55M	42.09%149.47M	-14.86%509.22M	-23.66%368.94M	-21.37%248.2M
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	--	--	Unqualified opinion	--	--	--	Unqualified opinion	--	--
Auditor	--	--	--	Lixin Certified Public Accountants (Special General Partnership)	--	--	--	Lixin Certified Public Accountants (Special General Partnership)	--	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More

牛牛課堂

Oct 13, 2025 18:05

[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?

Food流油

Apr 14, 2025 15:43

"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"